| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Geffner Michael serves as a Chief Medical Officer at IMVT. Across recent SEC filings that breaks down to 0 buys and 12 sells. Those positions are worth an estimated $8.9M at current prices.
Historically, Geffner Michael's trades have earned a middling insider score of 66/100 across 11 rated trades. Over a 12-month horizon, 66.7% of those trades were profitable, with an average 12-month return of +12.4%.
The biggest single holding is IMVT (~$8.9M) as Chief Medical Officer. The recent filings there lean toward selling, a net 38,594 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 26, 2024 | IMVT Immunovant, Inc. | Chief Medical Officer | Sell | 10,101 | $37.92 | $383,011.53 | -5.3% | -27.5% | -39.7% |